🇺🇸 FDA
Pipeline program

851B

1537-851B

Phase 2 small_molecule terminated

Quick answer

851B for Papillomavirus Infections is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Papillomavirus Infections
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials